Covid Study Concludes: Omicron More Resistant To Vaccines, But Less Severe Symptoms

Covid Study Concludes: Omicron More Resistant To Vaccines, But Less Severe Symptoms
SHARE

There has been a lot of fuss all over the world regarding the efficiency of covid vaccines against the novel variant of the coronavirus called Omicron.

People have also been wondering just how bad the symptomatology of this novel variant is, but experts have been highlighting that there are only mild symptoms involved.

Covid Omicron new study drops impressive conclusions

Now, it’s been revealed that a new study is addressing important conclusions about the novel variant of the virus. 

Washington Post revealed that Omicron seems to cause less severe illness than earlier variants of the coronavirus.

On the other hand, it’s also important to note the fact that this variant is more resistant to the two-dose Pfizer-BioNTech vaccine widely used in South Africa.

This is what the first major private study since Omicron was first detected last month.

“The study by Discovery Health, South Africa’s largest health insurer, of 211,000 positive coronavirus cases showed that the risk of hospital admissions among adults who contracted covid-19 was 29 percent lower than in the initial pandemic wave that emerged in March 2020.”

33% protection against Infection detected by the study 

On the other hand, it’s also important to mention the fact that the study found that the Pfizer-BioNTech vaccine provided just 33 percent protection against infection, much less than the level for other variants detected in the country so far.

At the same time, the vaccine provided 70% protection against severe complications that would require a patient to be hospitalized, the study found, calling that “very good protection.”

Source: reuters.com

It’s also worth noting the fact that the World Health Organization warned not too long ago that Omicron, now detected in 63 countries, poses a “very high” global risk.

“The drop in the protection of two doses of the Pfizer vaccine against any symptomatic infection is similar to what a British preprint study released late last week showed, namely that it dipped below 40 percent.”

Stay tuned for more news and also make sure to remain safe, you and your loved ones as well. 


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.